NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BioAmp Diagnostics

BioAmp Diagnostics

Private
San Carlos, CaliforniaHealthcare & Life Scienceshttps://bioampdx.com/

Last Round

Grant

Jan 15, 2023

Total Funding Raised

$1.58M

Company Overview

BioAmp Diagnostics is a biotechnology company that develops rapid, precision diagnostic tests designed to counteract antibiotic resistance by enabling medical providers to identify appropriate antibiotic treatments for bacterial infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

rapid diagnosticspoint-of-care testingPOCTantibiotic stewardshipurinary tract infectionUTIinfectious disease testingclinical diagnosticsmicrobiology testingdiagnostic assayantibiotic resistancemedical devicerapid testingbedside testingclinical research services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioAmp Diagnostics Comps

Public and private peers based on sector, stage, and business model.

BioAmp Diagnostics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BioAmp Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 15, 2023
AcceleratorOct 7, 2022
GrantMay 1, 2020
GrantFeb 1, 2020
AcceleratorApr 23, 2019
Accelerator
Jun 14, 2017

Key People

Founding team and executive leadership

Tara deBoer

CEO, Founder

Founding Team

BioAmp Diagnostics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 15, 2023

    $1M grant from the National Science Foundation.

  • May 1, 2020

    $225K grant from the National Science Foundation.

BioAmp Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioAmp Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioAmp Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Carlos, California
Employee Range7
Year Founded2017
Last FundingJan 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.